The company said that Nirmatrelvir and Ritonavir tablets in a combi pack as a treatment option for patients with mild to moderate symptoms ...

With the continuous rise in Omicron cases of Covid-19, patients are looking at various drug options to relieve some symptoms. US-based infe...

The experts of the task force cited safety concerns and argued that Molnupiravir was not of much benefit in Covid treatment to arrive at th...

The USFDA also said molnupiravir should be given to those for whom alternative Covid-19 treatment options authorised by it are not accessib...

The USFDA also said the drug should be given for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or cl...

The regulator also told the court that, apart from the Corona Kavach policy, there were over 19 products offered as insurance policy by gen...

The company has received permission for restricted emergency use of its monoclonal antibody drugs, bamlanivimab 700 mg and etesevimab 1400 ...

"We are motivated to serve patients in every possible way and with utmost urgency. This is reflected in the multiple collaborations we have...

The Hyderabad-based firm said it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company fo...

Favipiravir is one of the leading oral anti-viral treatment approved in various countries for the potential treatment of patients with mild...

Hospitals and pharmacists in major cities have reported acute shortage of the drug due to supply constraints and alleged hoarding.

Over 20 anti-viral drugs that were discontinued from manufacturing or had research on them halted because of other priorities have now beco...

In a regulatory filing, Zydus Cadila said "it has successfully completed a phase 2 clinical trial in COVID-19 patients with its biological ...

Zenara Pharma, a fully owned subsidiary of Biophore India Pharmaceuticals, announced that it has received approval from the Drugs Controlle...

The equine antisera pathway with which the Mumbai-based company is working is already used in treatments against snake bites, rabies and di...

A bench headed by Justice Ashok Bhushan issued notice to the Centre on the PIL filed by Avishek Goenka for fixing an upper limit of cost fo...

Move comes after Kerala used this approach. ICMR may release protocol in a couple of days. The convalescent plasma therapy works on the sci...